Key Health Benefits

Benefit Area	Description	PubMed Link
Glucose metabolism (T2DM insulin sensitivity)	In type 2 diabetic patients, supplementation with 400 µg/day chromium picolinate for 8 weeks significantly improved insulin resistance (lower HOMA-IR) and modestly improved lipid profile (reduced total and LDL cholesterol). Fasting glucose and body weight were unchanged, indicating a modest overall effect in that trial.	PMID: 32395440
Lipid profile (cholesterol support)	In a double-blind trial, chromium picolinate markedly improved blood lipids: total cholesterol, LDL-cholesterol and ApoB were significantly reduced, while the HDL-associated ApoA-I protein increased. These changes indicate an overall cholesterol-lowering and HDL-enhancing effect of CrPic.	PMID: 2408233
Eating behavior (appetite/BED)	In overweight adults with binge-eating disorder, chromium picolinate (600–1000 µg/day) over 6 months reduced fasting glucose and was associated with fewer binge-eating episodes and modest weight loss. Though this small pilot study was not fully powered for those outcomes, trends favored CrPic in reducing binge frequency and promoting weight loss.	PMID: 23751236
Polycystic ovary syndrome (PCOS)	In women with PCOS, 1000 µg/day CrPic for 6 months significantly lowered BMI and fasting insulin and raised the fasting glucose/insulin ratio (improved insulin sensitivity). Chromium nearly doubled the rates of ovulation and menstrual-cycle regularity compared to placebo, indicating metabolic and fertility benefits.	PMID: 26663540
Mood (atypical depression)	In a small randomized trial, 600 µg/day CrPic (for 8 weeks) produced a 70% responder rate in patients with atypical depression versus 0% in the placebo group, a highly significant difference (p=0.02). Chromium was well tolerated, suggesting a potential antidepressant-like effect in this population.	PMID: 12559660
Metabolic/inflammation (NAFLD)	In patients with non-alcoholic fatty liver disease, 400 µg/day CrPic for 3 months significantly reduced multiple metabolic and inflammatory markers: triglycerides, VLDL, insulin and HOMA-IR, and inflammatory cytokines (hs-CRP, IL-6, TNF-α) were all lowered, while insulin sensitivity (QUICKI) rose. This indicates broad metabolic and anti-inflammatory benefits of CrPic.	PMID: 33045675

 

Dosage Recommendation

Goal	Stack
Blood Sugar Control	200–400 mcg daily (1 capsule once or twice a day with meals)
Weight Support	200 mcg before breakfast and 200 mcg before dinner
Cholesterol Support	400 mcg daily, paired with omega-3 or niacin supplement
Appetite Management	200 mcg 30 minutes before lunch (optionally stacked with green tea extract)

Supplement Facts

NUTRITIONAL INFORMATION
Serving Size: 1 veg. Capsule
	Amt. per Serving	% RDA Men	% RDA Women
Chromium Picolinate	400mcg
D-Biotin	40mcg	100	100
Ingredients: Chromium Picolinate, D-Biotin, Bulking Agent INS 460 (i), Anticaking Agent INS 341(iii) & Vegetable Capsule Shell (HPMC) (INS 464)

When Will I See Results?

Goal	Expected Timeline
Blood Sugar Regulation	4–8 weeks for noticeable improvement in fasting blood glucose and HbA1c
Weight & Cravings	6–10 weeks for appetite reduction and potential body composition changes
Cholesterol Support	8–12 weeks for improvements in lipid panel (LDL/HDL balance)
Mood & Energy	2–4 weeks to notice better energy levels or emotional stability

How to Maximise Results

Goal	Stack
Glucose Control	Chromium + Berberine (500 mg) + Low-carb diet
Fat Reduction & Lean Muscle	Chromium + CLA (Conjugated Linoleic Acid) + Moderate resistance training
Cravings & Appetite	Chromium + 5-HTP (50–100 mg) + High-protein, low-GI meals
Mood & Fatigue	Chromium + Vitamin B complex + regular morning exposure to sunlight

What to Avoid

Substance	Reason to Avoid	Spacing Tip
Antacids / Calcium	May reduce chromium absorption	Take 1–2 hours apart from chromium
High Sugar Intake	Undermines blood glucose benefits	Avoid refined sugars while using chromium
Excessive Iron/Zinc	May compete with chromium for absorption pathways	Space by 2 hours if taking multivitamins with iron/zinc
Diabetic Medication	May have additive blood sugar-lowering effects	Monitor glucose regularly; consult your physician

Third Party NABL Lab Report

Third Party NABL Lab Report for Chromium Picolinate :

 

Click here to view the report